Carlos Zala

1.2k citations
36 papers · 905 indexed · h-index 17
Topics
HIV/AIDS drug development and treatment (24 papers)HIV Research and Treatment (20 papers)HIV/AIDS Research and Interventions (17 papers)

In The Last Decade

Carlos Zala

34 papers receiving 868 citations

Peers

Carlos Zala
Comparison fields: 5 of 69
  • Infectious Diseases 693
  • Virology 515
  • Emergency Medicine 309
  • Epidemiology 176
  • Endocrinology, Diabetes and Metabolism 59
Replace Jussara Silveira with:
Jussara Silveira Brazil
P. de Truchis France
Erin Quirk United States
Clare Brennan United States
Jacques Gilquin France
Brian Gazzard United Kingdom
Paola Cicconi Italy
Peter Gute Germany
Nicola Gianotti Italy
Judit Pich Spain
Carlos Zala relative to Jussara Silveira Brazil Jussara Silveira's profile →
Citations per field
00.5×4.5×
Jussara Silveira · 1×
Citations per year

Countries citing papers authored by Carlos Zala

Since Specialization
Citations

This map shows the geographic impact of Carlos Zala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Zala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Zala more than expected).

Fields of papers citing papers by Carlos Zala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Zala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Zala. The network helps show where Carlos Zala may publish in the future.

Co-authorship network of co-authors of Carlos Zala

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Zala. A scholar is included among the top collaborators of Carlos Zala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Zala. Carlos Zala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 66
4 8
5 55
6 41
7 11
8 42
9 14
10 45
11 35
12 78
13 18
14 1
15 28
16 16
17 29
18 61
19 10
20 26

About Carlos Zala

Carlos Zala is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 36 papers that have together received 905 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (20 papers) and HIV/AIDS Research and Interventions (17 papers). The work is most often cited by research in Virology (515 citations), Infectious Diseases (693 citations) and Emergency Medicine (309 citations). Carlos Zala has collaborated with scholars based in Argentina, Canada and United States. Frequent co-authors include Pedro Cahn, Julio Montaner, Horacio Salomón, Jeremy Roberts, Romina Quercia, Sandra Rae, Gustavo H. Kijak, Joan Montaner, Sandra Pampuro and Danielle Rouleau. Their work appears in journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026